Analyze Diet
Comparative biochemistry and physiology. B, Comparative biochemistry1989; 92(2); 399-403; doi: 10.1016/0305-0491(89)90300-3

Kinetic and inhibitory characteristics of serum angiotensin-converting enzyme from nine mammalian species.

Abstract: 1. Serum angiotensin-converting enzyme activities were obtained from nine mammalian species: rat, mouse, horse, sheep, guinea pig, hamster, rabbit, dog and man. 2. Kinetic constants (Km and Vmax) using hippuryl-L-histidyl-L-leucine as substrate and inhibitory constants (I50 and Ki) for captopril were determined for the serum ACE of each species. 3. There were important differences in the kinetic and inhibitory constants (Kms went from 6.6 mM to 1.21 mM for hamster and guinea pig; I50 ranged from 2100 nM to 3 nM for mouse and sheep) as well as differences in enzyme activity of the different species (values varied from 938 to 13 nmol hippuric acid/ml/min for guinea pig and dog serum).
Publication Date: 1989-01-01 PubMed ID: 2538295DOI: 10.1016/0305-0491(89)90300-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research conducted a comparative analysis of serum angiotensin-converting enzyme activities across nine mammalian species, while examining the kinetic and inhibitory constants using a standardized substrate and inhibitors.

Study Overview

  • The study was conducted to understand the kinetic and inhibitory characteristics of serum angiotensin-converting enzyme (ACE) across nine different species. The selected species for the study were rat, mouse, horse, sheep, guinea pig, hamster, rabbit, dog, and human.

Kinetic Evaluation

  • ACE activity in the serum of each species was analyzed using hippuryl-L-histidyl-L-leucine as the substrate.
  • The kinetic constants, represented by Km (the substrate concentration at which the reaction rate is half of its maximum) and Vmax (the maximum rate achievable by the system) were determined for each species’ serum ACE.

Inhibitory Evaluation

  • Similarly, the inhibitory constants, represented by I50 (the inhibitor concentration at which the reaction rate is reduced to half its maximum) and Ki (the inhibitor constant) were determined with the use of captopril, a medication used to treat high blood pressure, as an ACE inhibitor.

Findings

  • There were notable differences in the kinetic and inhibitory constants across the different species. For example, the Kms values ranged from 6.6 mM for hamsters to 1.21 mM for guinea pigs. This suggests that the reaction rate differs significantly between these two species.
  • The I50 values, representing the inhibitory potency of captopril, also ranged widely, from 2100 nM for mice to just 3 nM for sheep. This shows a significant variation in the sensitivity of ACE to captopril across different species.
  • There were also species-specific differences in enzyme activity levels. The study denotes these values ranging from 938 to 13 nmol hippuric acid/ml/min for guinea pig and dog serum respectively, implying variances in metabolic activity across these species.

Implication of Findings

  • The study’s findings highlight the variation in both the kinetic and inhibitory characteristics of mammalian ACE activity. This could have implications for understanding species-specific differences in physiological mechanisms and response to ACE inhibitors, such as captopril.

Cite This Article

APA
Ibarra-Rubio ME, Pena JC, Pedraza-Chaverri J. (1989). Kinetic and inhibitory characteristics of serum angiotensin-converting enzyme from nine mammalian species. Comp Biochem Physiol B, 92(2), 399-403. https://doi.org/10.1016/0305-0491(89)90300-3

Publication

ISSN: 0305-0491
NlmUniqueID: 2984730R
Country: England
Language: English
Volume: 92
Issue: 2
Pages: 399-403

Researcher Affiliations

Ibarra-Rubio, M E
  • Department of Nephrology and Mineral Metabolism, National Institute of Nutrition Salvador Zubirán, Delegación Tlalpan, D.F. México.
Pena, J C
    Pedraza-Chaverri, J

      MeSH Terms

      • Animals
      • Captopril / pharmacology
      • Cricetinae
      • Dogs
      • Guinea Pigs
      • Horses
      • Humans
      • Kinetics
      • Mice
      • Peptidyl-Dipeptidase A / blood
      • Rabbits
      • Rats
      • Sheep
      • Species Specificity

      Citations

      This article has been cited 4 times.
      1. Mueller S, Paegelow I, Reissmann S. Hypothesized and found mechanisms for potentiation of bradykinin actions.. Signal Transduct 2006 Feb;6(1):5-18.
        doi: 10.1002/sita.200500061pubmed: 32327962google scholar: lookup
      2. Macfadyen RJ, Lees KR, Reid JL. Perindopril. A review of its pharmacokinetics and clinical pharmacology.. Drugs 1990;39 Suppl 1:49-63.
      3. MacFadyen RJ, Lees KR, Reid JL. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.. Br J Clin Pharmacol 1991 Jan;31(1):1-13.
      4. MacFadyen RJ, Lees KR, Gemmill JD, Hillis WS, Reid JL. Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.. Br J Clin Pharmacol 1991 Aug;32(2):193-9.